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  ctinic cheilitis is a potentially malignant lip lesion caused by excessive and prolonged exposure to ultraviolet radiation, which
can lead to histomorphological alterations indicative of abnormal cell differentiation. In this pathology, varying degrees of epithelial
dysplasia may be found. There are few published studies regarding the p53 and MDM2 proteins in actinic cheilitis. Fifty-eight cases
diagnosed with actinic cheilitis were histologically evaluated using Banóczy and Csiba (1976) parameters, and were subjected to
immunohistochemical analysis using the streptavidin-biotin method in order to assess p53 and MDM2 protein expression. All
studied cases expressed p53 proteins in basal and suprabasal layers. In the basal layer, the nuclei testing positive for p53 were
stained intensely, while in the suprabasal layer, cells with slightly stained nuclei were predominant. All cases also tested positive for
the MDM2 protein, but with varying degrees of nuclear expression and a predominance of slightly stained cells. A statistically
significant correlation between the percentage of p53 and MDM2-positive cells was established, regardless of the degree of epithelial
dysplasia. The expression of p53 and MDM2 proteins in actinic cheilitis can be an important indicator in lip carcinogenesis,
regardless of the degree of epithelial dysplasia.
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INTRODUCTION
Regular and prolonged exposure to solar radiation can
lead to wide-spectrum tissue alterations ranging from atrophy
to dysplastic alterations in the labial mucosa, which can cause
histomorphological alterations indicative of abnormalities
in normal cell differentiation29. The most commonly
observed alteration in the lower lip is manifested as actinic
cheilitis, considered a premalignant lesion by the World
Health Organization24 (1997), with the possibility of a
malignant transformation in approximately 10 to 20% of
the cases10.
From a histopathological point of view, actinic cheilitis
is characterized by stratified squamous epithelium with
ortho- or parakeratinized hyperkeratosis. Areas of
acanthosis, atrophy and epithelial dysplasia can also be
observed. In the region subjacent to the epithelium, chronic
inflammatory infiltrates can be seen on the lamina propria
with amorphous basophilic degeneration of the collagen and
elastic fibers, known as solar elastosis, which is possibly a
result of ultraviolet radiation11,19,29.
During normal cell development, the p53 protein,
produced by the expression of the p53 gene, is not required.
However, in situations of cell stress, its expression is
stimulated. Therefore, when ionizing radiation, oxidative
reactions, hypoxemia and the action of oncogenic proteins
cause damage to DNA, p53 will be phosphorylated and
activated in its wild form. If this process fails, it will act in
the transcription of genes that control the cell cycle and
promote apoptosis5,26. UV-induced mutations of the p53 gene
not only abolish, but also stabilize the tumor suppressor
activity of the p53 protein, resulting in its accumulation to
levels that can be detectable immunohistochemically27.
Activation of p53 induces the expression of several genes
including the human homolog to the murine-double-minute
gene (mdm)-217. One of the mechanisms to activate the p53
protein is the formation of a complex with the MDM2
protein. This bond interrupts its transcriptional activity while
promoting its degradation and has been considered a
mechanism for malignant transformation3,13.
It is known that carcinogenesis is frequently associated
with protein expression, which allows for the identification
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of molecular alterations related to malignant transformation.
In oral carcinogenesis, p53 and MDM2 proteins are involved
in a complex manner, and other proteins, like p14 ARF, are
also engaged in these pathways. It may be clarified, when
considered that p14ARF interacts with the oncogenic protein
MDM2, inducing stabilization of p53 and enhancing p53-
related functions13. Furthermore, concomitant
immunopositivity for p14ARF and MDM2 overexpression
was found in oral squamous cell carcinoma, whereas an
inverse correlation between p14ARF and MDM2 expression
and diffuse staining of p53 were detected, showing that at
least one protein was altered in most cases28.
In the literature, a great deal of cases regarding the
expression of oncogenic proteins has been observed in oral
squamous cell carcinoma. However, few studies have been
referenced about the interaction of p53 and MDM2 in
premalignant oral lesions with neoplasmic potential, such
as actinic cheilitis. Thus, the aim of the present study was to
evaluate, using immunohistochemical techniques, p53 and
MDM2 protein expression in actinic cheilitis with different
degrees of epithelial dysplasia, in order to provide
information of a possible role of these biomarkers that can
contribute to a better understanding of the malignant
potential of this pathology.
MATERIAL AND METHODS
Fifty-eight cases of actinic cheilitis were selected for
this study from the archives of the Aristides Maltez Cancer
Hospital in Salvador, Bahia, Brazil. The histological sections
for each case were stained by hematoxylin and eosin (HE)
and subjected to morphological analysis under light
microscopy. The histological degree of epithelial dysplasia
was analyzed using the Bánoczy and Csiba4 (1976)
parameters based on the epithelial alterations defined by
the WHO24 (1997): presence of irregular epithelial
stratification, hyperplasia of the basal layer, presence of
rounded rete pegs, increased number of suprabasal mitoses,
loss of basal layer cell polarity, increased nucleus-
cytoplasmic ratio, nuclear polymorphism and
hyperchromatism, enlarged nucleoli, keratinization of single
cells or cell groups in the prinkle layer, and loss of
intercellular adhesion. The lesions were classified as mild,
when two of these alterations were present; moderate, when
three or four of the alterations were present, and severe when
five or more of the above mentioned alterations were
observed.
Immunohistochemical Procedures
The evaluation of p53 and MDM2 proteins was carried
out by immunohistochemical analysis using the streptavidin-
biotin method. Four-micrometer-thick tissue sections were
obtained, deparaffinized and subjected to antigen recovery
treatment. This was done by placing the slides, soaked in a
citrate buffer target retrieval solution, pH 6.0 at 97°C, in a
double boiler for 30 min for MDM2 and 10 min for p53.
The primary monoclonal mouse p53 antibody (DO-7,
DAKO; 1:50 dilution) was incubated for 1 h and the
monoclonal mouse MDM2 antibody (SMP14, DAKO; 1:40
dilution) for 16 h at room temperature. After incubating the
primary antibodies, the sections were exposed to the
streptavidin-biotin complex. The DO-7 anti-p53 antibody
detects both mutant and wild-type p53. In order to develop
the reaction, a 0.03% diaminobenzidine chromogenic
solution was used with 1 mL of H2O2 for five min in a dark
room. Then, counterstaining was carried out with Harris
hematoxylin. As a positive control of the p53 protein,
histological sections of squamous lip cell carcinoma were
used and for the MDM2 protein sections of colon
adenocarcinoma. The negative controls were obtained by
substituting the primary antibody for a buffer solution. For
assessing the immunostaining, the samples were analyzed
by the mean percentage of positive cells determined from
the percentage of total positive and negative cells derived
from 10 random areas at ×400 magnification and classified
semi-quantitatively as described by Lu et al. (1999):18 0 (0%
positive cells); +1 (<10% positive cells); +2 (10-50%
positive cells); +3 (>50% positive cells). Furthermore, an
immunostaining pattern was performed to classify
epithelium compartment involvement (basal layer
expression, suprabasal layer expression or both).
Statistical Analysis
The correlation between the expression of p53 and
MDM2 proteins and the degree of epithelial dysplasia was
carried out using the non-parametric Spearman rank
correlation test. The mean values of cells testing positive
for the p53 and MDM2 proteins were also compared in the
different types of epithelial dysplasia using Student’s t-test
at 5% significance level.
RESULTS
Histopathological Findings
The sections from the 58 cases of actinic cheilitis were
analyzed with a light microscope, revealing lesions lined
with stratified squamous epithelium and varying degrees of
keratinization, with a predominance of orthokeratinized
epithelium. The lamina propria, represented by a narrow
strip of dense conjunctive tissue, was vascularized and
infiltrated by lymphoplasmacytic cells. Subjacent to this
region, an extensive area of amorphous, basophilic material
was observed, which was interpreted as solar elastosis.
According to the histological grading system used by
Banóczy and Csiba4 (1976), 12 cases were classified as
moderate epithelial dysplasia, and 46 cases as severe. Among
the cases of epithelial dysplasia, the most common
histological alterations observed were the loss of basal cell
polarity and nuclear hyperchromatism (93.1%) followed by
nuclear polymorphism (79.3%), and the occurrence of
rounded or rounded rete pegs (70.6%) (Figure 1).
Immunohistochemical Analysis
The immunohistochemical expression for the p53
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proteins was observed in all the cases of actinic cheilitis,
with the nuclear staining pattern expressed in the basal and
suprabasal layers. The positive nuclei for p53 showed an
intense immunostaining in basal layer cells (Figure 2A),
while in the suprabasal layer there was a predominance of
slightly stained nuclei (Figure 2B). The labeling of the
MDM2 protein was also observed in all cases, but with
different intensities of nuclear staining and a predominance
of a more discrete expression. Most cases (58%) showed
immunoreactivity to MDM2 in the basal layer only, and the
remaining cases (42%) showed immunoreactivity to MDM2
in both the basal and the suprabasal layers (Figure 3A). The
positive cells in the suprabasal layer were sparsely
distributed (Figure 3B). The sections analyzed showed only
areas of actinic cheilitis.
In the semiquantitative analysis, the majority of cases
was classified as +3 (>50% positive cells) for the p53 (n=51)
and MDM2 (n=38) proteins. The cases classified as +2 (10-
50% positive cells) summed 12% for the p53 protein (n=7)
and 32 % for the MDM2 protein (n=19). No cases of actinic
cheilitis were observed with less than 10% of the cells testing
FIGURE 1- Severe epithelial dysplasia in actinic cheilitis.
Nuclear hyperchromatism of basal cells (arrow), nuclear
polymorphism and rounded rete pegs (asterisk). HE ×200
FIGURE 2- Mild and Moderate epithelial dysplasia in actinic cheilitis. Discrete p53 nuclear immunostaining only in basal layer
cells (A); p53 nuclear immunostaining in suprabasal layer cells (B). Streptavidin-biotin ~ ×400
FIGURE 3- Mild and Moderate epithelial dysplasia in actinic cheilitis. Intense MDM2 nuclear immunostaining in all stratified
epithelium cells (A); MDM2 nuclear immunostaining predominantly in suprabasal layer cells (B). Streptavidin-biotin ~ ×400
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positive for the p53 protein and only 1 case had a +1 score
for the MDM2 protein.
No statistically significant difference was observed in
the mean number of cells testing positive for the p53 and
MDM2 proteins in the types of epithelial dysplasia studied
(p53: p=0.099; MDM2: p=0.378, Chi-square). A statistically
significant correlation was observed between the percentage
of cells testing positive for the p53 and MDM2 proteins in
the 58 cases of actinic cheilitis. This correlation was not
dependent on the degree of epithelial dysplasia (Table 1).
In this study, normal mucosa and areas exposed to the sun
without the presence of actinic cheilitis were not analyzed.
The objective was to compare the expression of both type
of proteins, only in mucosa with actinic cheilitis.
DISCUSSION
Alterations in the regulation of the different proteins
involved in the cell cycle have already been observed in the
earliest phases of oral cancer. Previous studies6,27,26,32
confirmed that the expression of certain proteins, such as
p53, can be significantly altered both in the cases of epithelial
dysplasia as well as in oral squamous cell carcinomas. In
the genesis of malignant lip lesions, the mutation and
expression of the p53 protein can be associated with the
action of specific carcinogens such as ultraviolet radiation6,16.
In the literature, the studies on the expression of this protein,
as well as its ability to aid in predicting the prognosis, have
been carried out were carried out on different types of
premalignant lesions. There are few specific studies on cases
of actinic cheilitis. In the present study, p53 protein
expression was confirmed in all cases of actinic cheilitis.
These results were similar to those of Crosthwaite, et al.6
(1996), which that showed high expression levels in all cases
of actinic cheilitis and skin keratosis. Other authors found
different results in the levels of positive responses to this
protein that ranged from 20 to 92% in different types of
oral premalignant lesions14,27. Neto Pimentel, et al.23 (2006)
found 85% of immunoreactivity to the p53 protein in actinic
cheilitis  and suggested that this lesion already have p53
gene abnormalities. These authors concluded that the
percentage of stained nuclei for the p53 protein in the
cheilitis and the presence of squamous cell carcinoma of
the lip were not significantly associated, and questioned the
role of a high immunoreactivity index as a marker of
evolution into an invasive carcinoma.
Martinez, et al.20 (2005) observed p53 high expression
in normal lip mucosa exposed to solar radiation. This
variability in the results is probably due to the diversity of
the biochemical characteristics of p53 protein10, but the
distinct premalignant lesions studied and the sensitivity of
the immunohistochemical technique used should also be
considered20. In this context, it can be inferred that mutation
of gene p53 in lesions caused by the direct effects of
ultraviolet light, represents an independent mechanism,
different to oral leukoplasias in which smoking and alcohol
consumption are considered determining factors. Once
mutated, the p53 gene undergoes conformational and
structural alterations that causes its deactivation and make
it impossible to carry out its function. This deactivation leads
to a greater stabilization that considerably increases its half-
life, allowing for protein identification by
immunohistochemical methods7,17. Although considered rare
events, the presence of “nonsense” mutations or the deletion
of  both alleles of gene p53 prevents its translation due to
the production of unstable proteins that interfere directly in
its expression and detection30.
During the immunohistochemical analysis of the AC
cases, we observed that p53 protein expression occurred in
both basal and suprabasal layer epithelial cells. Equal
immunolocalization has been obtained by other authors in
different cases of premalignant oral lesions6,9,14,15,23, although
Argawal, et al.2 (1998) observed that the p53 protein was
only expressed in the nucleus of basal layer epithelial cells
in cases of oral leukoplasias. It is implied that p53 protein
expression in keratinocytes, and not in differentiated cells,
supports the potential role of p53 in preventing early
carcinogenesis31. Therefore, alterations in gene p53 might
be involved in initial events of oral carcinogenesis, occurring
before coarse phenotypic alterations25. These outcomes have
been emphasized by Tron, et al.31 (1998) and Martínez, et
al.21 (2008), who found a significantly increased p53
expression in AC cases when compared to normal lip and
oral mucosa. We consider p53 suprabasal expression in
actinic cheilitis an advanced process in lip carcinogenesis.
However, in the same way as other authors12,2,5 we could
not demonstrated that p53 protein presence is related to the
degree of epithelial dysplasia.
Since the lip is a transition tissue between skin and oral
mucosa, expression of p53-regulated genes in the lip could
differ from both intraoral and skin malignancies, which has
been shown by Martínez, et al.21 (2008) in the epithelial
layers of AC lesions compared to normal lip, where both
p53 and MDM-2 were significantly up-regulated. MDM2,
when bonding to the p53 activation domain, inhibits its
ability to stimulate transcription and also leads to its rapid
degradation using the ubiquitin system22,30. In the present
study, the expression of the MDM2 protein, one of the main
negative regulators of the p53 protein, was also evaluated.
The expression of MDM2 was observed in all the cases of
actinic cheilitis presented herein, although with a lower
expression intensity in relation to the p53 protein. This result
Epithelial   n     Correlation p
Dysplasia (p53 and MDM2)
Moderate 12 0.67420 0.0162*
Severe 46 0.50620 0.003*
Moderate 58 0.53455 0.0001*
+ severe
TABLE 1- Correlation between p53 and MDM2 proteins in
severe and moderate epithelial dysplasia
*Significant level at 5%. Spearman Test.
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differs from those obtained by Crosthwaite, et al.6 (1996),
where 60% of the cases of epithelial dysplasias that
expressed the MDM2 protein presented an intense degree
of nuclear staining. We observed as well that the expression
of the MDM2 protein occurred in both basal and suprabasal
layers in 42% of the cases and in the basal layer only in
58% of the cases regardless the degree of epithelial
dysplasia. However, Ganguli, et al.8 (2000) observed the
expression of the MDM2 protein in premalignant skin
lesions only in the nuclei of basal layer epithelial cells.
Yanamoto, et al.32 (2002) studied a significant number
of oral squamous cell carcinoma and confirmed a correlation
between the superexpression of the MDM2 protein and an
unfavorable prognosis for the disease. Overexpression of
MDM-2 has also been associated with increased
malignancy1. Regarding actinic cheilitis, it was observed
here that the superexpression of this protein occurred in both
moderate and severe types of epithelial dysplasia, which
have a higher risk for malignant transformation.
Furthermore, the present study established a statistically
significant correlation between the expression of p53 and
MDM2 proteins in cases of actinic cheilitis. Similar results
regarding the expression of these proteins were observed in
oral leukoplasias as well as in oral squamous cell
carcinoma2,20. This factor probably demonstrates that the
MDM2 protein is involved in the accumulation of the p53
protein in oral carcinogenesis and especially in the genesis
of lip cancer. Likewise, Martínez, et al.21 (2008) considered
increased p53 expression as a predictor of premalignancy
in the lip, suggesting that its detection may be a valuable
tool in AC diagnosis.
CONCLUSIONS
In conclusion, the results showed a high percentage of
immunostaining, both for p53 and for MDM2 in cases of
AC, which suggest a possible role of these biomarkers in
lip carcinogenesis, independent of the disease stage.
Furthermore, a significant correlation was observed in the
expression of these proteins, regardless the  epithelial
dysplasia degree, which demonstrates an aggressive state
for this lesion.
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